Bariatric Surgery Market

Regional governments in developed countries increase reimbursement coverage and sponsor bariatric surgery boosting the market growth

According to the World Health Organization's 2016 data review, 1.9 billion people worldwide are overweight, of which 650 million are obese. Nearly 13% of the population aged 18 and over are obese, and 41 million children under 5 are obese. The American Heart Association estimates total healthcare costs will increase from $861 billion to $957 billion by 2030. Colossal healthcare spending is forcing governments to take action to reduce the incidence of obesity and obesity-related long-term chronic diseases. It. In 2017, the U.S.

Centers for Disease Control and Prevention (CDC) awarded approximately $8.5 million in funding to all 50 states and the District of Columbia to strengthen strategies to reduce obesity in areas with high obesity rates.

The market is primarily driven by the rising prevalence of obesity among adults and increasing operational efficiency by cutting-edge robotics. The National Institute for Health and Care Excellence (NICE) recommends bariatric surgery over lifestyle and medication and also recommends early consideration of surgery for people with diabetes. These developments are expected to drive market growth in the coming years. Moreover, increasing reimbursement coverage and sponsorship of bariatric surgery by local governments in developed countries is expected to drive market growth.

Obesity is one of the significant health concerns increasing the demand for gastric bypass surgery globally. Diabetes and cardiovascular devices are major diseases prevalent in the obese population. The emergence of new technologies in bariatric surgery, rising patient numbers, and growing demand for minimally invasive surgical procedures are the critical drivers for the growth of the bariatric surgery market over the forecast period. Therefore, the Bariatric Surgery Market CAGR has been increasing globally in recent years. These are essential factors driving the growth of the Bariatric Surgery Market revenue.

The aging population worldwide presents a unique challenge and opportunity for the Global Bariatric Surgery Market Industry. Older adults are more susceptible to obesity and its associated health complications, necessitating effective weight management solutions. As life expectancy increases, the demand for bariatric surgeries is likely to rise, as older individuals seek to improve their quality of life. This demographic shift is expected to drive market growth, with projections indicating a significant increase in the number of procedures performed. By 2035, the market could expand to 6.11 USD Billion, reflecting the growing need for tailored surgical interventions for the aging population within the Global Bariatric Surgery Market Industry.

The increasing prevalence of obesity globally serves as a primary driver for the Global Bariatric Surgery Market Industry. According to data, the World Health Organization indicates that obesity rates have tripled since 1975, with over 650 million adults classified as obese in 2022. This alarming trend is likely to propel the demand for bariatric surgeries, as individuals seek effective solutions for weight management. The market is projected to reach 2.34 USD Billion in 2024, reflecting a growing recognition of surgical interventions as viable options for severe obesity. As awareness of obesity-related health risks increases, the Global Bariatric Surgery Market Industry is expected to expand significantly.

Innovations in surgical techniques and technologies are transforming the landscape of the Global Bariatric Surgery Market Industry. Minimally invasive procedures, such as laparoscopic surgeries, have gained traction due to their reduced recovery times and lower complication rates. The introduction of robotic-assisted surgeries further enhances precision and patient outcomes. These advancements not only improve the efficacy of bariatric procedures but also attract a broader patient demographic. As a result, the market is anticipated to grow, with projections indicating a rise to 6.11 USD Billion by 2035. The integration of cutting-edge technology is likely to play a pivotal role in shaping the future of the Global Bariatric Surgery Market Industry.

The Global Bariatric Surgery Market Industry is characterized by dynamic trends and projections that indicate substantial growth. The market is expected to reach 2.34 USD Billion in 2024, with a robust compound annual growth rate of 9.12% anticipated from 2025 to 2035. This growth is driven by factors such as rising obesity rates, technological advancements, and increased awareness of surgical options. The market's trajectory suggests a promising future, with potential expansions in both developed and emerging economies. As healthcare systems adapt to the growing demand for bariatric procedures, the Global Bariatric Surgery Market Industry is poised for significant transformation.

The escalation of healthcare expenditure globally is another significant driver for the Global Bariatric Surgery Market Industry. As countries invest more in healthcare infrastructure and services, access to surgical interventions improves. This trend is particularly evident in developed nations, where healthcare systems are increasingly prioritizing obesity treatment. For instance, the United States has seen a surge in insurance coverage for bariatric procedures, making them more accessible to patients. This increase in healthcare spending is likely to facilitate the growth of the market, with projections suggesting it will reach 2.34 USD Billion in 2024. Enhanced access to bariatric surgery is expected to contribute positively to the Global Bariatric Surgery Market Industry.

There is a growing awareness and acceptance of bariatric surgery as a legitimate treatment for obesity and related comorbidities. Public health campaigns and educational initiatives have contributed to changing perceptions, highlighting the benefits of surgical interventions. This shift in mindset is crucial for the Global Bariatric Surgery Market Industry, as it encourages individuals to consider surgery as a viable option. Moreover, healthcare providers are increasingly recommending bariatric procedures as part of comprehensive weight management strategies. As awareness continues to rise, the market is expected to experience a compound annual growth rate of 9.12% from 2025 to 2035, indicating a robust future for the Global Bariatric Surgery Market Industry.

By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North America Bariatric Surgery Market accounted for USD 0.8 billion in 2022. It is expected to exhibit a significant CAGR growth during the study period due to Awareness of obesity and its risk factors and technological advances in laparoscopic bariatric surgery continuing to increase. The North American bariatric surgery market is the largest, followed by South America. Furthermore, obesity is one of the major health concerns among the U.S. population, thereby increasing the need for surgical procedures.

Further, the significant countries studied in the market report are The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: BARIATRIC SURGERY MARKET SHARE BY REGION 2022 (%)

Europe's Bariatric Surgery Market accounts for the second-largest market share. An increasing number of surgical equipment manufacturers and distributors, a high prevalence of diabetes, and massive government funding for research drive the European bariatric surgery market. Germany holds the largest market share, followed by France and the United Kingdom. Factors boosting the market's growth in Germany are the concentration of key players and their focus on diabetes and obesity management. Further, the Germany Bariatric Surgery Market held the largest market share, and the U.K. Bariatric Surgery Market was the fastest-growing market in the European Region.

The Asia-Pacific Bariatric Surgery Market is expected to grow at the fastest CAGR from 2024 to 2030. In the Asia-Pacific region, diabetes is one of the major chronic diseases that impose an economic burden on developing economies such as China and India. Availability of skilled healthcare professionals (i.e., surgeons), rising Awareness among patients about obesity, and rising geriatric population are key factors contributing to market growth. In India and China, the growing influence of the Western lifestyle, lack of physical activity, and sedentary lifestyle among the working population are major risk factors for obesity, accelerating market growth.

Furthermore, the prevalence of obesity is also increasing in Asia Pacific, affecting the regional market. Moreover, the China Bariatric Surgery Market held the largest market share, and the India Bariatric Surgery Market was the fastest-growing market in the Asia-Pacific region.

Major market players are spending a lot on R&D to increase their product lines, which will help the Bariatric Surgery Market grow even more. Market participants are also taking various strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the Bariatric Surgery industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

Manufacturing locally to reduce operating costs is one of the primary business strategies manufacturers adopt in the global Bariatric Surgery industry to benefit clients and expand the market sector. The Bariatric Surgery industry has provided medicine with some of the most significant benefits in recent years. Major players such as Apollo Endosurgery Inc., Johnson & Johnson Services Inc., Olympus Corporation, ALLERGAN, TransEnterix Surgical, Inc., Cousin Biotech in the Bariatric Surgery Market markets EndoGastric Solutions, Inc., and others are working on expanding the market demand by investing in research and development activities.

ReShape Lifesciences® is the world's premier weight loss solutions company, offering a comprehensive portfolio of proven products and services for managing and treating obesity and metabolic disease. In August 2022, ReShape Lifesciences™ received US FDA clearance for the GIBI HD gastrointestinal balloon indicator. The new solution includes three new sizes, viz. 32, 36, and 40, designed to simplify bariatric procedures such as laparoscopic sleeve gastrectomy, adjustable gastric banding, and gastric bypass surgery.

Also, Johnson & Johnson Services Inc. provides consumer healthcare products. The company offers healthcare products in feminine hygiene, baby care, facial skin care, beauty, wound care, cough and cold, oral care, and over-the-counter products. Johnson & Johnson Services serves clients worldwide. In June 2022, Johnson & Johnson rolled out the Echelon 3000, a next-gen stapler, in the US. The new digitally-enabled stapler aimed to offer surgeons simple and one-handed powered articulation. Moreover, the new solution also aids in addressing the root causes of several surgical complications to navigate the varying needs of each patient's anatomy successfully.